Pascaline Boudou‐Rouquette

<i>TP53, STK11</i> , and <i>EGFR</i> Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma

Jérôme Biton, Audrey Mansuet‐Lupo, Nicolas Pécuchet et al. · Clinical Cancer Research · 2018 · 348 citations

Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study

Florence Duffaud, Olivier Mir, Pascaline Boudou‐Rouquette et al. · The Lancet Oncology · 2018 · 304 citations

Oncology, Adult Patients, Metronomic Therapy +8

Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma

Olivier Mir, Romain Coriat, Benoı̂t Blanchet et al. · PLoS ONE · 2012 · 294 citations · Full text

Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients

Olivier Huillard, Olivier Mir, Michaël Peyromaure et al. · British Journal of Cancer · 2013 · 221 citations · Full text

Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group

Nicolas Penel, Axel Le Cesne, Sylvie Bonvalot et al. · European Journal of Cancer · 2017 · 178 citations

Fibrosis, Surgical Pathology, Pathology +3